BRCA2 and ovarian neoplasm: Analyses of survival and matched genotype and expression data from TCGA datasets indicated that CHAF1A expression can stratify the survival of individuals with BRCA2-mutant ovarian tumors: high CHAF1A expression trended towards increased survival, while low CHAF1A expression trended towards reduced survival (Supplementary Fig. 2c).